3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
15
Phase 2
10
Phase 1/2
6
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
8
Recurrence
3
Astrocytoma
3
Gliosarcoma
2
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Pituitary Neoplasms
1
Oligodendroglioma
1
Non Small Cell Lung Cancer Metastatic
1
Melanoma
1
Medulloblastoma
1
Glioma
1
Ependymoma
1
Brain Neoplasms
1
Advanced Glioblastoma
1
Interventions
Carboplatin
2
trofosfamide
1
Vincristine
1
Thiotepa
1
Temozolomide
1
Radiotherapy
1
Maintenance Chemotherapy
1
Lomustine
1
Induction Chemotherapy
1
Etoposide
1
Diploidy
1
Cyclophosphamide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Medulloblastoma
×
Temozolomide
×
Clear all
NCT00749723
2018-07-20
HIT-REZ-2005
University Hospital, Bonn
Phase 2/3
Completed
174 enrolled